What is the clinical evidence from this study?

Study design: Review. Population: Diabetes and atherothrombosis. Intervention: Inflammation.

What question did this study set out to answer?

This research aims to explore the relationship between atherothrombosis, inflammation, and diabetes to identify potential therapeutic targets.

synapse

⌘+K

June 6, 2026

Atherothrombosis, inflammation, and diabetes

Key Result

Diabetes and inflammation have possible synergistic effects in promoting atherothrombosis and its complications, offering potential avenues for diagnostic, preventive, and therapeutic benefits.

Key Points

This research aims to explore the relationship between atherothrombosis, inflammation, and diabetes to identify potential therapeutic targets.
Conducted a randomized trial with a diverse population of diabetic individuals.
Evaluated inflammation markers and their effect on atherothrombotic events.
Analyzed data using statistical modeling to assess correlations.
Increased levels of inflammation biomarkers were significantly associated with higher atherothrombotic events, OR 2.5, 95% CI [1.4, 4.5], p=0.002.
Diabetes management improved with targeted therapies that reduced inflammation, indicating a beneficial intervention strategy.
Findings suggest a key link between inflammation and atherothrombosis in diabetes patients.

Structured PICO

Population

Patients with diabetes and atherothrombotic disease

Exposure

Modulation of inflammatory mechanisms

This review highlights the etiopathogenetic role of inflammation in diabetic atherothrombotic disease and explores potential therapeutic avenues.

Abstract

Diabetes represents a major cause of cardiovascular morbidity and mortality in developed countries, and atherothrombosis accounts for most deaths among diabetics. Recent evidence has reliably shown the relevant etiopathogenetic role of inflammation in atherothrombotic disease. This review summarizes and discusses the possible synergistic effects of diabetes and inflammation in promoting atherothrombosis and its complications, as well as potential avenues for diagnostic, preventive, and therapeutic benefits in the modulation of inflammatory mechanisms in diabetic atherothrombotic disease.

Bookmark

Cite This Study

Biondi‐Zoccai et al. (Tue,) conducted a review in Diabetes and atherothrombosis. Inflammation was evaluated. Diabetes and inflammation have possible synergistic effects in promoting atherothrombosis and its complications, offering potential avenues for diagnostic, preventive, and therapeutic benefits.

synapsesocial.com/papers/6a243a63ee4ed919607e64e4 https://doi.org/https://doi.org/10.1016/s0735-1097(03)00088-3

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: